Cardiac Dimensions Funding: $200M Raised, Series E (2025)
Cardiac Dimensions is a Biotech company based in Kirkland. It has raised $200M in total funding. Latest round: Series E.
Cardiac Dimensions funding overview
Cardiac Dimensions is a Biotech company based in Kirkland. Cardiac Dimensions has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in March 2025. The round record for Cardiac Dimensions runs through 2025; nothing later has been disclosed. Investors on record include Ally Bridge Group, Claret Capital Partners, Hostplus, M.H. Carnegie, Horizon 3 Healthcare, Lumira Ventures. 6 distinct backers are named across the disclosed rounds.
Cardiac Dimensions has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Cardiac Dimensions?
Ally Bridge Group, Claret Capital Partners, Hostplus, M.H. Carnegie, Horizon 3 Healthcare, Lumira Ventures are named among the investors backing Cardiac Dimensions.
What was the latest Cardiac Dimensions funding round?
The most recent disclosed round is a Series E, announced in March 2025.
Where is Cardiac Dimensions based?
Cardiac Dimensions is based in Kirkland.
What sector does Cardiac Dimensions operate in?
Cardiac Dimensions is tracked under Biotech from Kirkland, with $200M in disclosed funding.
When did Cardiac Dimensions last raise?
The last disclosed Cardiac Dimensions round closed in March 2025 at Series E.
Cardiac Dimensions totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Kirkland below to benchmark round size and investor mix.
